Zlobin A - Search Results

1

Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells.

Weijzen S, Rizzo P, Braid M, Vaishnav R, Jonkheer SM, Zlobin A, Osborne BA, Gottipati S, Aster JC, Hahn WC, Rudolf M, Siziopikou K, Kast WM, Miele L. Weijzen S, et al. Among authors: zlobin a. Nat Med. 2002 Sep;8(9):979-86. doi: 10.1038/nm754. Epub 2002 Aug 19. Nat Med. 2002. PMID: 12185362

2

HPV16 E6 and E7 oncoproteins regulate Notch-1 expression and cooperate to induce transformation.

Weijzen S, Zlobin A, Braid M, Miele L, Kast WM. Weijzen S, et al. Among authors: zlobin a. J Cell Physiol. 2003 Mar;194(3):356-62. doi: 10.1002/jcp.10217. J Cell Physiol. 2003. PMID: 12548555

3

Notch signaling as a target in multimodality cancer therapy.

Jang MS, Zlobin A, Kast WM, Miele L. Jang MS, et al. Among authors: zlobin a. Curr Opin Mol Ther. 2000 Feb;2(1):55-65. Curr Opin Mol Ther. 2000. PMID: 11249652 Review.

4

Notch-1 regulates cell death independently of differentiation in murine erythroleukemia cells through multiple apoptosis and cell cycle pathways.

Jang MS, Miao H, Carlesso N, Shelly L, Zlobin A, Darack N, Qin JZ, Nickoloff BJ, Miele L. Jang MS, et al. Among authors: zlobin a. J Cell Physiol. 2004 Jun;199(3):418-33. doi: 10.1002/jcp.10467. J Cell Physiol. 2004. PMID: 15095289

5

Toward the rational design of cell fate modifiers: notch signaling as a target for novel biopharmaceuticals.

Zlobin A, Jang M, Miele L. Zlobin A, et al. Curr Pharm Biotechnol. 2000 Jul;1(1):83-106. doi: 10.2174/1389201003379013. Curr Pharm Biotechnol. 2000. PMID: 11467364 Review.

6

Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas.

Song L, Zlobin A, Ghoshal P, Zhang Q, Houde C, Weijzen S, Jiang Q, Nacheva E, Yagan D, Davis E, Galiegue-Zouitina S, Catovsky D, Grogan T, Fisher RI, Miele L, Coignet LJ. Song L, et al. Among authors: zlobin a. Cancer Res. 2005 Jun 1;65(11):4554-61. doi: 10.1158/0008-5472.CAN-04-4108. Cancer Res. 2005. PMID: 15930272 Free article.

7

Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells.

Cheng P, Zlobin A, Volgina V, Gottipati S, Osborne B, Simel EJ, Miele L, Gabrilovich DI. Cheng P, et al. Among authors: zlobin a. J Immunol. 2001 Oct 15;167(8):4458-67. doi: 10.4049/jimmunol.167.8.4458. J Immunol. 2001. PMID: 11591772

8

PKCα Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab Resistance.

Pandya K, Wyatt D, Gallagher B, Shah D, Baker A, Bloodworth J, Zlobin A, Pannuti A, Green A, Ellis IO, Filipovic A, Sagert J, Rana A, Albain KS, Miele L, Denning MF, Osipo C. Pandya K, et al. Among authors: zlobin a. Clin Cancer Res. 2016 Jan 1;22(1):175-86. doi: 10.1158/1078-0432.CCR-15-0179. Epub 2015 Sep 8. Clin Cancer Res. 2016. PMID: 26350262 Free PMC article.

9

Gamma secretase inhibitors of Notch signaling.

Olsauskas-Kuprys R, Zlobin A, Osipo C. Olsauskas-Kuprys R, et al. Among authors: zlobin a. Onco Targets Ther. 2013 Jul 23;6:943-55. doi: 10.2147/OTT.S33766. Print 2013. Onco Targets Ther. 2013. PMID: 23901284 Free PMC article.

10

Osteopontin mediates an MZF1-TGF-β1-dependent transformation of mesenchymal stem cells into cancer-associated fibroblasts in breast cancer.

Weber CE, Kothari AN, Wai PY, Li NY, Driver J, Zapf MA, Franzen CA, Gupta GN, Osipo C, Zlobin A, Syn WK, Zhang J, Kuo PC, Mi Z. Weber CE, et al. Among authors: zlobin a. Oncogene. 2015 Sep 10;34(37):4821-33. doi: 10.1038/onc.2014.410. Epub 2014 Dec 22. Oncogene. 2015. PMID: 25531323 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

56 results

Search Page